An interventional study of Pancreatic duct stenting in Pancreatic Surgery, Pancreatic Duct Stenting and Pancreatic Cancer, sponsored by Massachusetts General Hospital. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-06-11.
Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Prevention
The purpose of this study is to investigate an intervention to prevent complications after pancreas surgery. The goal is to determine if placing a stent into the pancreatic duct before surgery will decrease or prevent leaking from the pancreatic duct after surgery. Leaks are common after pancreas surgery and can result in serious problems and post-operative pain. The study will compare two groups. One group will have the stent before surgery, and the other group will have standard pancreas surgery, no endoscopy, and no stent.
94 studies on the registry are indexed under Pancreatic Cyst; 34 are open to participants now.
Browse Pancreatic Cyst studies →Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.
Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Pre-operative pancreatic duct stenting
Procedure: Pancreatic duct stenting
Control group, no endoscopy and no stent pre-operatively
In the treatment arm, patients will have a pancreatic duct stent placed prior to having their distal pancreatectomy.
Pancreatic leak
Time frame: Post-operative day 3
Peritoneal fluid analysis
Time frame: Daily
Serum biochemical analysis
Time frame: Daily
Clinical outcomes
Time frame: Daily
This study is withdrawn, as verified in Jun 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Massachusetts General Hospital